Business Combinations, Asset Acquisitions, and Joint Venture Formation (Tables)

6 Months Ended

Jun. 27, 2025

Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]

Business Combination, Preliminary Consideration

The preliminary consideration is calculated as follows (dollar amounts in millions except exchange ratio and share price):

Endo common shares outstanding as of July 31, 2025	76,313,462
Per Share Stock Consideration	0.2575
Mallinckrodt ordinary shares issued in exchange	19,650,663
Mallinckrodt closing stock price (1)	$	92.30
Preliminary estimated fair value of Mallinckrodt ordinary shares issued	$	1,813.8
Other cash consideration (2)	0.0
Payment to Endo stockholders	100.0
Other merger consideration attributable to Endo stock-based awards	7.1
Obligation to cash settle shares underlying certain Endo stock-based awards	2.4
Total preliminary consideration	$	1,923.3

(1)Mallinckrodt is not listed on a national securities exchange or quoted on the automated quotation system of a national securities association, and as such, used a preliminary fair value per ordinary share as of July 31, 2025 in accordance with U.S. Internal Revenue Service Section 409A to determine preliminary fair value of consideration transferred. Due to the timing of the acquisition, the preliminary 409A is subject to change.

(2)Other cash consideration represents less than $0.1 million of aggregate cash payments to Endo stockholders in lieu of any fractional shares.